Meeting
2021 ASCO Annual Meeting
The impact of tumor infiltrating lymphocytes (TILs) on disease progression in human papillomavirus (HPV)-related oropharyngeal squamous cell carcinoma.
Authors
Linda X Yin
Department of Otorhinolaryngology, Mayo Clinic, Rochester, MN
Linda X Yin , Michael Rivera , Joaquin J. Garcia , Kathleen Bartemes , Derrick B Lewis , Christine M. Lohse , David Routman , Daniel Jeng-Lin Ma , Eric J. Moore , Kathryn M. Van Abel
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Head and Neck Cancer
Track
Head and Neck Cancer
Sub Track
Biologic Correlates
Citation
J Clin Oncol 39, 2021 (suppl 15; abstr 6049)
DOI
10.1200/JCO.2021.39.15_suppl.6049
Abstract #
6049
Poster Bd #
Online Only
Abstract Disclosures
Similar Posters
Poster
2018 ASCO Annual Meeting
PATHOS: A phase II/III trial of risk-stratified, reduced intensity adjuvant treatment in patients undergoing transoral surgery for human papillomavirus (HPV)-positive oropharyngeal cancer.
First Author: Mererid Evans
First Author: Evgeny Izumchenko
Poster
2023 ASCO Annual Meeting
Phase 2 trial of three schedules of CUE-101 administered before surgery or chemoradiotherapy in HLA-A*0201 positive patients with HPV16+ OPSCC.
First Author: Jesse Meir Zaretsky
Poster
2021 ASCO Annual Meeting
Ultra-sensitive detection and quantification of HPV DNA in the plasma of patients with oropharyngeal squamous cell carcinoma (OPSCC) enrolled in the OPTIMA 2 treatment de-escalation trial.
First Author: Hillary Sloane